Logo

PerkinElmer

JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More

Highlights of the second day included Myriad Genetics' new oncology testing service and more details on SomaLogic's partnership with Illumina.

Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results

Other companies reporting preliminary Q4 financial results included Fluidigm, SomaLogic, and T2 Biosystems.

GW Index Rises 3 Percent in December

Waters and Bio-Techne rebounded after falling in November, but Burning Rock and Genetron both saw sharp declines.

PerkinElmer Q3 Revenues Grow 21 Percent

The company's Diagnostics segment posted $654 million in revenues, while its Discovery and Analytical Solutions had $513 million in revenues.

New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More

Oct 7, 2021

FDA Issues Emergency Use Authorization for PerkinElmer COVID-19/Flu Test

Sep 9, 2021

PerkinElmer Prices Senior Notes Offering

Aug 25, 2021

PerkinElmer Reaches Deal for $1.5B Credit Facility

Aug 12, 2021

PerkinElmer Enters $500M Credit Facility

Aug 2, 2021

GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases

Jun 1, 2021

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

May 28, 2021

In Brief This Week: Bio-Rad, 10x Genomics, IsoPlexis, 23andMe, PerkinElmer, LifeBit Biotech, More

Apr 13, 2021

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Mar 25, 2021

Euroimmun to Sell Oncgnostics Cervical Cancer Test in Certain Parts of Europe

Mar 4, 2021

PerkinElmer to Offer $800M in Senior Notes

Feb 2, 2021

PerkinElmer Q4 Revenues Spike 68 Percent

Jan 11, 2021

PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

Jan 11, 2021

PerkinElmer Q4 Revenues Expected to Rise 66 Percent

Jan 7, 2021

PerkinElmer to Buy Oxford Immunotec for $591M

Dec 14, 2020

Euroimmun SARS-CoV-2, Influenza A/B Test Gets CE Mark

Dec 1, 2020

Horizon Discovery Licenses Gene-Edited Cell Line to Sanyou Biopharmaceuticals

Nov 30, 2020

Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing Program

Nov 20, 2020

Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers
Premium

Nov 12, 2020

PerkinElmer Coronavirus RT-PCR Assay Receives CE Mark for Saliva Use, Sample Pooling

Nov 2, 2020

PerkinElmer to Buy Horizon Discovery for $383M

Breaking News
The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.